Investors responded positively to healthcare stocks on Monday. Key movement were observed in Merge Healthcare Inc (NASDAQ:MRGE) and Obagi Medical Products, Inc (NASDAQ:OMPI) on percentage decliners side while Johnson & Johnson (NYSE:JNJ) was prominent stock on most active side.
Anacor Pharmaceuticals Inc (NASDAQ:ANAC) reported that the Bill & Melinda Gates Foundation decided to pay $17.7 million to support the healthcare company’s development of drugs for tuberculosis and 2 filarial worm diseases. The Gates Foundation will invest $5 billion in Anacor stock under the research agreement.
Anacor Pharmaceuticals Inc’s YTD performance was recorded as 31.54% while its market capitalization was $243.29 million. Institutional ownership owns 81.38% shares of the company while beta factor, which is used to measure riskiness of the security, was 0.27. Net profit margin of the company was -578.82%.
Merz Pharma Group pulled out it’s almost $385 million offer to purchase Obagi Medical Products, Inc (NASDAQ:OMPI), mentioning Valeant Pharmaceuticals Intl Inc (NYSE:VRX) sweetened offer for the specialty-pharmaceutical corporation previous week.
Obagi Medical Products, Inc. has market capitalization of $418.07 million. Its current ratio was 3.58 while its shares were looking forward SMA50 with 51.28. The company offered earnings per share of 0.91 while its 17.43 million shares were outstanding. YTD performance of the stock was 76.45%.
Valeant Pharmaceuticals Intl Inc (NYSE:VRX) has the market capitalization of $22.05 billion. The company’s EPS was -0.38 while its 298.06 million shares were outstanding. Its institutional ownership was 95.80%. Shares of the company were moving ahead of SMA50 with 2.10% while its YTD performance was 70.60%.
DO NOT TRADE ANY STOCK WITHOUT LEVEL 2 STOCK QUOTES! QuoteDaddy.com delivers it's user with the most in-depth Level 2 Quotation System available on the Planet! NO Downloads, NO Widgets, NO Plugins required! Stay on TOP of your trades with QuoteDaddy.com! CLICK HERE TO START YOUR FREE 30-DAY TRIAL